Table 3

Baseline values for scores

PP population (N=35)
MusiQoL index improved
MusiQoL index worsened
Sex (n (%)
7 (33.3)
14 (66.7)
7 (50.0)
7 (50.0)
Education (n (%)
   Primary education (basic)
   Secondary education (technical college)
   Tertiary education (university)
7 (33.3)
9 (42.9)
5 (23.8)
2 (14.3)
11 (28.6)
1 (7.1)
MusiQoL index (N=35)66.7±13.866.2±13.367.4±15.1
EDSS score (n=21)3.04±1.192.83±1.223.36±1.12
ARR at baseline—all relapses (n=20)0.9±0.71.2±0.70.5±0.5
ARR at baseline—relapses requiring steroid treatment (n=20)0.6±0.70.9±0.70.3±0.3
FSMC total score (n=21)57.7±23.654.3±23.263.2±24.1
BDI-FS (n=15)2.6±2.92.7±3.22.3±2.6
SDMT (n=21)49.6±12.153.1±10.644.3±12.6
MSISQ-19 total38.7±15.336.1±14.642.6±16.0
MSISQ-19 primary causes of sexual dysfunction (n=21)10.8±5.79.7±5.312.6±6.0
MSISQ-19 secondary causes of sexual dysfunction (n=21)18.3±6.617.5±6.719.6±6.4
MSISQ-19 tertiary causes of sexual dysfunction (n=21)9.5±5.19.0±5.310.4±4.9
EQ-5D index (n=21)0.838±0.1510.853±0.1260.814±0.184
EQ-5D VAS (n=21)70.3±22.569.7±19.071.3±27.6
WPAI presenteeism (n=12)30.0±30.135.0±32.115.0±19.1
WPAI absenteeism (n=12)16.4±34.921.8±39.20
WPAI productivity loss (n=12)38.7±35.646.6±36.915.0±19.1
WPAI activity impairment (n=12)35.6±27.640.8±27.820.0±23.1
  • The results are shown as mean±SD. PROs were secondary outcomes; not all values were available for all 35 patients, particularly BDI-FS and WPAI.

  • ARR, annualised relapse rate; BDI, Beck Depression Inventory; EDSS, Expanded Disability Status Scale; EQ-5D, EuroQoL-5 Dimension; FSMC, Fatigue Scale of Motor and Cognitive Function; MSISQ, Multiple Sclerosis Intimacy and Sexuality Questionnaire-19; PRO, patient-reported outcome; SDMT, Symbol Digit Modalities Test; VAS, visual analogue scale; WPAI, Work Productivity and Activity Impairment in MS.